Validation Study

Risks & contraindications

Evidence quality

Highlighted claims

• The validation study was conducted in Spanish primary schools during the 2022-2023 and 2023-2024 school years. — Test to assess claims about treatment effects for Spanish primary school children: the development process and cross-sectional validation study of the test
• Nine primary schools and 480 children participated in the validation study. — Test to assess claims about treatment effects for Spanish primary school children: the development process and cross-sectional validation study of the test
• Most children answered all 24 IHC assessment questions, and missing responses for each item were at most 7.7%. — Test to assess claims about treatment effects for Spanish primary school children: the development process and cross-sectional validation study of the test
• Children in the validation study had no prior knowledge of or contact with the IHC project. — Test to assess claims about treatment effects for Spanish primary school children: the development process and cross-sectional validation study of the test
• The validation used a strategic sample with substantial representation from one Spanish region, which may limit generalisability. — Test to assess claims about treatment effects for Spanish primary school children: the development process and cross-sectional validation study of the test